SOD1 and in situ carcinoma: CIS treatment significantly increased MDA levels in both liver (Fig. 3) and kidney (Fig. 4) tissues compared to the control group, while GSH levels, along with SOD and CAT activities, were substantially decreased (p < 0.0001).